HIGHLIGHTS
- who: Ying He and collaborators from the Department of Gynecology, Affiliated Hospital of Hebei North University, Zhangjiakou, China, Department of have published the research: Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer, in the Journal: (JOURNAL)
- what: Bevacizumab combined with pemetrexed exhibits certain efficacy in the treatment of recurrent and metastatic cervical cancer, with tolerable adverse reactions.
SUMMARY
Patients with recurrent and metastatic cervical cancer are usually treated by means of chemotherapy, surgery and/or radiotherapy, but they have a poor prognosis. Bevacizumab can . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.